The Ki-67 proliferation index, assessed with an 80% cut-off, showed that only 18.4% of DLBCL NOS cases had high proliferative activity, compared to 35.3% in double expressor cases (Figure 3). This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.